-------- Original Message --------
ChartAdvisor | | | You are receiving this third party advertisement as a result of your subscription to the ChartAdvisor QQQQ Report. To unsubscribe see below. | | 
This Historical Breakthrough Promises To KILL Cancer Cells For GOOD. OncoSec Medical (ONCS) Has Deciphered the Rosetta Stone
of Cancer Research.
This is NOT a theory. That's why I see this stock that's priced at just about $1, hitting $38 in four months...
Dear reader, When the history of cancer research is written, I'm confident Oncosec Medical (ONCS) will be the greatest unknown winner. Here's why... ONCS ha s developed a new way of stopping cancer cells using a small field of electricity that makes the cancer cell absorb Bleomycin, a potent cancer killer. Healthy cells are left unharmed! It's a breakthrough in treating devastating cancers of the neck, head and skin without resorting to painful and risky surgery that's now standard. HERE'S WHAT ONCOSEC'S ASTOUNDING TECHNOLOGY OFFERS:
 | The ability to wipe out deadly cancer cells...Drastically, if not completely eliminating scarring and disfigurement... Surgery that took two hours can now take 15 minutes with this new technique...It costs up to 67% less...Healthy cells are saved, sick ones are destroyed. |  | These 4 spectacular benefits alone make OncoSec Medical, Inc. (ONCS) at around $1 a share a spectacular takeover candidate like Cougar Biotechnology that was purchased at $43 a share! I believe that OncoSec Medical could attract a $38 a share bid |  | Acquisit ion In the Biotech Field Are Going Through the Roof.
"We Expect This Trend to Continue. Small Biotech Companies
Are Game for Such Deals," Says Daily Markets Daily Markets then says, "Companies have been looking towards biotech companies to build their product portfolios. Prime examples include Johnson & Johnson's acquisition of Cougar Biotechnology, Inc." Precisely. I'm predicting that this can happen to OncoSec Medical, Inc. (ONCS). Do yourself a favor. Call your discount broker now and secure some of OncoSec Medical's stock before the word gets out. I'm predicting that this breakthrough will sweep the Internet. YOUR TIMING IS KEY: Wall Street Looks for Stocks Like
OncoSec Medical, Inc. (ONCS) because They Know the
Profit Potential Is Absolutely Astronomical Don't wait - the two most important words that can be said about this undervalued gem. At about a buck it is a screaming steal considering how bright its future is. Come join us!
My Best, 
Shawn Ambrosino
Editor, M3 Profit Accelerator |  | M3 Profit Accelerator, P.O. Box 243805, Boynton Beach, FL 33424
TrinityInvestmentResearch.com | 
| | | You are currently subscribed to chartadvisor-offers as: nbrauchitsch@yahoo.com
To unsubscribe or change your email settings, click here. | | |
This is a commercial email, it may contain advertisement or solicitation.
If you have any further questions or concerns contact us by writing: Investopedia US, a division of Valueclick, Inc. Suite 200, 4208 - 97th Street Greystone
Business Park Edmonton, AB Canada T6E 5R7. We are in full compliance with the US 2003 CAN-SPAM Act, and the Canadian Personal
Information Protection and Electronic Documents Act (PIPEDA). We endeavor to maintain the highest standards of
professionalism and corporate responsibility, and appreciate any comments from our customers. You may review our Privacy Policy here.
DISCLAIMER - This advertisement has been sent from ChartAdvisor.com to our Members on behalf of a third-party advertiser. We do not endorse the foregoing, and we assume no responsibility for the purchase and/or use thereof. ChartAdvisor.com is not recommending the above-mentioned stock. We did not draft the above advertisement. We strongly encourage you to independently verify all claims contained in the above advertisement. We also strongly encourage you to independently investigate the company or investment opportunity. ChartAdvisor is not a registered Investment Adviser or a Broker/Dealer. The trading of securities may not be suitable for all potential users of the Service. You should be aware of the risks inherent in the stock market. Past performance does not guarantee or imply future success. You cannot assume that profits or gains will be realized. The purchase of securities discussed ma y result in the loss of some or all of any investment made. We recommend that you consult a stockbroker or financial advisor before buying or selling securities, or making any investment decisions. You assume the entire cost and risk of any investing and/or trading you choose to undertake. We do not hold a position, nor do we endorse or recommend any securities mentioned in this mailing, but we do take compensation to the sum of ten thousand three hundred dollars for sending this mailing. Please read our full disclosure here.
No comments:
Post a Comment